Re: Ketogenic diet 심혈관질환 사망율 감소 2024 nature

[문형철]

1. nature  
2. scientific reports  
3. articles  
4. article

The ketogenic diet has the potential to decrease all-cause mortality without a concomitant increase in cardiovascular-related mortality

Download PDF

• Article
• Open access
• Published: 01 October 2024

The ketogenic diet has the potential to decrease all-cause mortality without a concomitant increase in cardiovascular-related mortality

• Xiaolong Qu, 
• Lei Huang & 
• Jiacheng Rong 

Scientific Reports volume 14, Article number: 22805 (2024) Cite this article

• 20k Accesses

• 106 Altmetric

• Metricsdetails

Abstract

The impact of the ketogenic diet (KD) on overall mortality and cardiovascular disease (CVD) mortality remains inconclusive.This study enrolled a total of 43,776 adults from the National Health and Nutrition Examination Survey (NHANES) conducted between 2001 and 2018 to investigate the potential association between dietary ketogenic ratio (DKR) and both all-cause mortality as well as cardiovascular disease(CVD) mortality.Three models were established, and Cox proportional hazards regression analysis was employed to examine the correlation. Furthermore, a restricted cubic spline function was utilized to assess the non-linear relationship. In addition, subgroup analysis and sensitivity analysis were performed.In the adjusted Cox proportional hazards regression model, a significant inverse association was observed between DKR and all-cause mortality (HR = 0.76, 95% CI = 0.63–0.9, P = 0.003). However, no significant association with cardiovascular mortality was found (HR = 1.13; CI = 0.79–1.6; P = 0.504). Additionally, a restricted cubic spline(RCS) analysis demonstrated a linear relationship between DKR and all-cause mortality risk. In the adult population of the United States, adherence to a KD exhibits potential in reducing all-cause mortality risk while not posing an increased threat of CVD-related fatalities.

초록

케토제닉 식이요법(KD)이 전체 사망률 및 심혈관 질환(CVD) 사망률에 미치는 영향은 아직 명확하지 않습니다. 본 연구는 2001년부터 2018년까지 실시된 국가 건강 및 영양 조사(NHANES)에서 모집된 43,776명의 성인을 대상으로 식이 케토제닉 비율(DKR)과 전체 사망률 및 심혈관 질환(CVD) 사망률 간의 잠재적 연관성을 조사했습니다. 세 가지 모델을 수립하고 Cox 비례 위험 회귀 분석을 통해 상관 관계를 분석했습니다. 또한 제한적 큐빅 스플라인 함수를 활용해 비선형 관계를 평가했으며, 하위 그룹 분석과 민감도 분석도 수행했습니다. 조정된 Cox 비례 위험 회귀 모델에서 DKR과 전체 사망률 사이에 유의미한 역상관 관계가 관찰되었습니다(HR = 0.76, 95% CI = 0.63–0.9, P = 0.003). 그러나 심혈관 사망률과의 유의미한 연관성은 발견되지 않았습니다(HR = 1.13; CI = 0.79–1.6; P = 0.504). 또한 제한적 큐빅 스플라인(RCS) 분석은 DKR과 전체 사망률 위험 사이의 선형 관계를 보여주었습니다.

미국 성인 인구에서 KD 준수은

전체 사망률 위험을 감소시키는 잠재력을 보여주며,

심혈관 질환 관련 사망 위험을 증가시키지 않습니다.

Similar content being viewed by others

Association of dietary niacin intake with all-cause and cardiovascular mortality: National Health and Nutrition Examination Survey (NHANES) 2003–2018

Article Open access16 November 2024

Association between dietary inflammatory index and all-cause mortality risk in adults with coronary heart disease in the United States

Article Open access14 October 2024

The correlation between Life’s essential 8 and cardiovascular disease and mortality in individuals with nonalcoholic fatty liver disease: a cross-sectional study

Article Open access14 October 2024

Introduction

The ketogenic diet(KD) is characterized by an extremely low carbohydrate intake, high fat consumption, and moderate protein intake. In recent years, it has garnered attention due to its potential benefits in weight loss, epilepsy management, and impact on metabolic diseases1,2. This dietary approach induces a shift from carbohydrate metabolism to fat metabolism within the body, resulting in the production of ketones such as acetoacetate and β-hydroxybuty-rate. This metabolic switch is believed to offer various health advantages including improved insulin sensitivity, reduced inflammation, and enhanced cognitive function3,4,5. Although the KD has been utilized for decades in treating childhood epilepsy, its application in other health conditions remains a topic of intense debate and further exploration, particularly regarding its effects on overall mortality rate and cardiovascular disease(CVD) risk.

CVD risk is a significant contributor to global morbidity and mortality, with dietary factors playing a pivotal role in its pathogenesis. Recent research has elucidated the intricate and nuanced relationship between the KD and CVD risk. On one hand, reducing carbohydrate intake and enhancing insulin sensitivity may confer beneficial effects on CVD risk factors such as blood pressure and lipid levels6,7. Conversely, the high-fat content of the KD, particularly saturated fat, may exert detrimental effects on lipid metabolism, trigger inflammatory responses, and augment CVD risk8,9. These contradictory findings underscore the imperative for further investigation into the long-term implications of the KD on mortality rates and CVD risk.

Based on the research background, the objective of this study is to utilize comprehensive information from the National Health and Nutrition Examination Survey (NHANES) data spanning 2001–2018 in the United States. This dataset encompasses dietary intake, anthropometric measurements, laboratory testing, and health outcomes, enabling an exploration into the impact of a KD on all-cause mortality and CVD mortality risk10. The NHANES dataset represents a large-scale nationally representative survey conducted on the U.S. population, providing invaluable resources for investigating long-term effects of various dietary patterns on health, including the KD.

This study aims to rigorously examine and meticulously analyze the long-term effects of a KD on mortality rates and CVD risk while gaining deeper insights into its impact on health. Ultimately, these findings aim to contribute towards developing scientifically accurate dietary guidelines and public health strategies that can extend lifespan and reduce chronic disease burden. Furthermore, these findings may offer significant implications for chronic disease management as well as promoting healthy aging processes.

소개

케토제닉 다이어트(KD)는 극히 낮은 탄수화물 섭취, 높은 지방 섭취, 그리고 적당한 단백질 섭취로 특징지어집니다. 최근 몇 년간 체중 감량, 간질 관리, 대사 질환에 미치는 영향 등 잠재적 이점으로 인해 주목을 받고 있습니다1,2. 이 식이 접근법은 체내에서 탄수화물 대사에서 지방 대사로의 전환을 유도하여 아세토아세테이트와 β-하이드록시부티레이트와 같은 케톤체의 생성을 유발합니다. 이 대사 전환은 인슐린 감수성 개선, 염증 감소, 인지 기능 향상 등 다양한 건강상의 이점을 제공할 것으로 추정됩니다3,4,5. KD는 수십 년간 소아 간질 치료에 활용되어 왔지만, 다른 건강 상태에 대한 적용은 특히 전체 사망률과 심혈관 질환(CVD) 위험에 미치는 영향 측면에서 여전히 뜨거운 논쟁과 추가 연구의 대상입니다.

CVD 위험은 전 세계 질병 부담과 사망률의 주요 요인이며, 식이 요인은 그 발병에 결정적인 역할을 합니다. 최근 연구는 KD와 CVD 위험 간의 복잡하고 미묘한 관계를 밝혔습니다. 한 편으로, 탄수화물 섭취 감소와 인슐린 감수성 향상은 혈압과 지질 수치 등 CVD 위험 요인에 유익한 영향을 미칠 수 있습니다6,7. 반면, KD의 높은 지방 함량, 특히 포화 지방은 지질 대사 장애를 유발하고 염증 반응을 촉진하며 CVD 위험을 증가시킬 수 있습니다8,9. 이러한 상반된 결과는 KD가 사망률과 CVD 위험에 미치는 장기적 영향에 대한 추가 연구의 필요성을 강조합니다.

본 연구의 목적은 2001년부터 2018년까지 미국에서 수집된 국가 건강 및 영양 조사(NHANES) 데이터의 포괄적인 정보를 활용하는 것입니다. 이 데이터셋은 식이 섭취, 인체 측정, 실험실 검사, 건강 결과 등을 포함하여 KD가 전체 사망률과 CVD 사망 위험에 미치는 영향을 탐구할 수 있습니다10. NHANES 데이터셋은 미국 인구를 대상으로 실시된 대규모 전국 대표 조사로, KD를 포함한 다양한 식이 패턴의 장기적 건강 영향 연구에 귀중한 자원을 제공합니다.

이 연구는 KD가 사망률과 CVD 위험에 미치는 장기적 영향을 엄격히 검토하고 세밀하게 분석하며, 그 건강 영향에 대한 깊은 통찰을 얻는 것을 목표로 합니다. 궁극적으로 이 연구 결과는 수명을 연장하고 만성 질환 부담을 줄이는 데 기여할 수 있는 과학적으로 정확한 식이 지침과 공중 보건 전략 개발에 기여할 것입니다. 또한 이 결과는 만성 질환 관리 및 건강한 노화 과정 촉진에 중요한 시사점을 제공할 수 있습니다.

Methods

Study design and participants

This cohort study utilized data from the nine national health and nutrition examination survey (NHANES) cycles conducted between 2001 and 2018, which included at least one dietary recall assessment (https://www.cdc.gov/nchs/NHANES/index). NHANES is a cross-sectional study initiated in 1999 by the National Center for Health Statistics (NCHS), aiming to eval‎uate the health and nutritional status of the non-institutional civilian population in the United States. To supplement this study, we linked the NHANES database from 2001 to 2018 with the NHANES Public Use Associated Mortality Archive, providing mortality follow-up data until December 31, 2019 (https://www.cdc.gov/nchs/data-linkage/ mortality.htm).The selection process of the study population is depicted in Fig. 1. A total of 91,351 participants were initially included in the retrospective cohort study. However, individuals below the age of 20 (N = 41,150), those with missing CVD data (N = 491), missing dietary data (N = 5619), missing follow-up data (N = 79), and those with missing covariate data (N = 236) were excluded from the analysis. Consequently, complete information on 43,776 adults was ultimately considered for the final analysis. All participants provided written informed consent, and the trial protocol of this study has been approved by the Ethics Review Committee at the National Center for Health Statistics.

방법

연구 설계 및 대상자

이 코호트 연구는 2001년부터 2018년까지 실시된 9개의 국가 건강 및 영양 조사(NHANES) 사이클에서 수집된 데이터를 활용했으며, 이 중 최소 한 번의 식이 회상 평가가 포함되었습니다(https://www.cdc.gov/nchs/NHANES/index). NHANES는 1999년 미국 국립 보건 통계 센터(NCHS)에서 시작된 횡단면 연구로, 미국 내 비기관 거주 민간 인구의 건강 및 영양 상태를 평가하는 것을 목적으로 합니다. 이 연구를 보완하기 위해 2001년부터 2018년까지의 NHANES 데이터베이스와 NHANES 공공 사용 연관 사망 기록 아카이브를 연결하여 2019년 12월 31일까지의 사망 추적 데이터를 제공했습니다(https://www.cdc.gov/nchs/data-linkage/ mortality.htm). 연구 대상 인구 선정 과정은 그림 1에 표시되어 있습니다. 초기에는 91,351명의 참가자가 회고적 코호트 연구에 포함되었습니다. 그러나 20세 미만(N = 41,150), 심혈관 질환(CVD) 데이터가缺如된 경우(N = 491), 식이 데이터가缺如된 경우(N = 5,619), 추적 데이터가缺如된 경우(N = 79), 공변량 데이터가缺如된 경우(N = 236)는 분석에서 제외되었습니다. 결국, 최종 분석에 포함된 성인 참가자의 완전한 정보는 43,776명입니다. 모든 참가자는 서면 동의서를 제출했으며, 본 연구의 시험 프로토콜은 국가 건강 통계 센터의 윤리 검토 위원회에서 승인되었습니다.

Fig. 1

Flow diagram of the study participant selection. NHANES, National Health and Nutrition Examination Survey; CVD, cardiovascular diseases.

Full size image

Dietary intake data

Dietary intake data were collected through two 24-hour retrospective NHANES surveys conducted by trained dietary investigators. The initial survey was administered face-to-face, followed by a subsequent telephone survey within three to 10 days. In the follow-up survey, participants were requested to recall and report the types and quantities of various foods and beverages consumed in the preceding 24 h, with dietary intake estimated based on the average of these two recalls11. Energy and nutrient intakes for all food items were calculated using the Food and Nutrition database in dietary studies12.

The dietary ketogenic ratio(DKR)

To eval‎uate dietary patterns for achieving nutritional ketosis, we calculated the Dietary Ketogenic Ratio (DKR) based on the proportion of macronutrients in the diet with ketogenic and antiketogenic properties. The DKR for macronutrients was determined using the equation developed by Withrow13. Essentially, this calculation involves dividing (0.9×grams of fat + 0.46×grams of protein) by (0.1×grams of fat + 0.58 × grams of protein + grams of net carbohydrates), resulting in values ranging from 0 to 9. A higher DKR value indicates a greater likelihood of inducing nutritional ketosis.

Outcome variables

In this study, we eval‎uated all-cause mortality as the primary outcome measure, with secondary outcomes including mortality related to CVD. Information regarding vital status of participants was acquired from publicly accessible mortality data files. To establish a connection between death records in the National Death Index and continuous NHANES data, both probabilistic and deterministic approaches were employed by the National Center for Health Statistics. The success rate for establishing linkages surpassed 99%14. The observation period began at baseline (defined as the date of NHANES participation) and ended either upon occurrence of death or on December 31st, 2019.

Covariates

Information regarding sociodemographic and lifestyle characteristics was obtained from demographics and questionnaire data. This included information on age(Youth group,≤40 years; Middle-aged group, 40–60 years and Elderly group, ≥60 years), gender, Race/ethnicity (Mexican American、Non-Hispanic White、Non- Hispanic Black、Other Hispanic、Other Race), educational level(Less than High school、High school/GED, More than high school), family income to poverty ratio (PIR), marital status(Married, Widowed, Divorced, Separated, Never married, Living with partner), smoking status, and BMI (<18.5 kg/m2,18.5–24 kg/m2, 24–28 kg/m2, ≥28 kg/m2). Participants were categorized as smokers if they responded affirmatively to the query, “Have you smoked at least 100 cigarettes in your entire life?” Conversely, those who answered negatively were classified as non-smokers. Standing height (centimeter, cm) and weight (kilogram, kg) were measured at the mobile examination center. The Body Mass Index (BMI, kg/cm2) was calculated by dividing the weight by the square of standing height.

Participants were considered to have a history of cardiovascular disease if they had been diagnosed by a medical professional with congestive heart failure(CHF), coronary heart disease(CHD), angina/angina pectoris, and myocardial infarction(MI). The presence of hypertension, stroke, and cancer/malignancy was determined through questionnaire responses. The definition of hypertension encompassed self-reported hypertension, systolic blood pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mm Hg, or documented use of antihypertensive medication.Diabetes was defined as HbA1c ≥ 6.5% or self-reported use of glucose-lowering medications.

Multiple imputation techniques were employed to handle missing values in covariates, with the percentage of missing values being less than 10%. These covariates included PIR (missing 7.8%), BMI (missing 1.5%), hypertension (missing 0.2%), and no variables exhibited missing values exceeding 10%.

Statistical analysis

The participants were categorized into two groups based on their survival status.

The baseline characteristics were subjected to descriptive analysis, with continuous variables presented as mean ± standard deviation (SD) or median (interquartile range), while categorical variables were reported as counts and percentages.Between-group comparisons were conducted using appropriate statistical tests: the Student’s t-test for normally distributed continuous variables, the Wilcoxon rank-sum test for non-normally distributed variables, and the chi-square test for categorical variables.

The associations between DKR and all-cause and cardiovascular mortality were eval‎uated using multivariate Cox proportional hazard models, yielding hazard ratios (HRs) along with their corresponding 95% confidence intervals (CIs).The quartiles of DKR were utilized to calculate HRs, with Q1 serving as the reference group in Model A, which incorporated unadjusted covariates. Model B was adjusted for age, education level, race, marital status, and PIR. In Model C, additional covariates including BMI, diabetes mellitus, CHF, CHD, angina pectoris, MI, stroke history, and cancer diagnosis were included.

To investigate the dose-response relationship between DKR and all-cause and CVD mortality, we utilized multivariable adjusted restricted cubic splines (RCS) in model C to explore potential non-linear associations.

The statistical significance was determined at a two-tailed p-value of less than 0.05. All data were analyzed using SPSS 27 software. The data were generated by GraphPad Prism 9.4 and R version 3.6.

Results

Baseline characteristics of the participants

The baseline characteristics of the participants are presented in Table 1. Among the final cohort of 43,776 participants, the mean age was 49.4 ± 18.1 years, with a female representation of 2,532 (48.3%). Following a median follow-up period of 9.1 years, all-cause mortality was observed in 6,054 participants (13.8%), while cardiovascular mortality occurred in 1,533 individuals (3.5%). Table 1 presents the baseline characteristics of both the survival and death groups; statistically significant differences were found across all variables (P < 0.05). In comparison to the death group, the survival group exhibited a higher proportion of females and younger individuals who identified as Mexican American and were married with higher levels of education and household income; they also had lower rates of smoking and BMI values. Additionally, compared to the death group, the survival group demonstrated lower preval‎ence rates for comorbidities such as diabetes mellitus, CVD, stroke, and cancer.

Table 1 Patient demographics and baseline characteristics.

Full size table

DKR and all-cause mortality

In this study, we developed three Cox regression models to investigate the association between DKR and all-cause mortality (refer to Table 2). The unadjusted model A did not demonstrate a statistically significant relationship between DKR and the risk of all-cause mortality(HR = 1.10, 95%CI = 0.93–1.3, P = 0.255). However, after adjusting for multiple variables in the multivariate analysis, we observed a significant inverse association between DKR and the risk of all-cause mortality. Specifically, as DKR increased, there was a substantial decrease in mortality risk. This finding remained consistent in both model B (HR = 0.80, 95%CI = 0.67–0.9, P = 0.015) and model C (HR = 0.76, 95%CI = 0.63–0.9, P = 0.003). Notably, in model C where adjustments were made for all variables considered relevant to our study population’s characteristics and confounding factors alike; each standard deviation increase in DKR resulted in a noteworthy 24% reduction in the risk of death.Furthermore when comparing patients within different quartiles after adjusting for multiple variables using multivariate analysis, it was found that patients within lower quartiles exhibited lower hazard ratios compared to those within higher quartiles.This trend consistently persisted both in model B (HR = 0.90; 95% CI = 0.83 -0.96; P = 0.003) as well as being replicated by similar results obtained from model C (HR = 0.86; CI = 0.80–0.93; P < 0.001).In the adjusted C model accounting for all covariates, our RCS analysis revealed a linear correlation between DKR and all-cause mortality. Notably, the dose-response relationship exhibited a significant inverse trend, indicating a progressive reduction in all-cause mortality with increasing DKR (refer to Fig. 2).

Table 2 HRs and 95% CI for all-cause and Cardiovascular mortality according to quartiles of DKR.

Full size table

Fig. 2

RCS analysis on the association between the DKR and the risk of all-cause mortality and CVD mortality. (A) RCS curve of the association between the DKR and all-cause mortality, (B) RCS curve of the association between the DKR and CVD mortality. RCS: restricted cubic spline; CVD, Cardiovascular Disease; DKR, Dietary ketogenic ratio.

Full size image

DKR and CVD mortality

We constructed three COX regression models to eval‎uate the association between DKR and the risk of CVD mortality. However, none of the three models demonstrated a statistically significant association between DKR and CVD mortality risk (Model A: HR = 1.31; CI = 0.94–1.8; P = 0.113, Model B: HR = 1.32; CI = 0.93–1.8; P = 0.124, or Model C: HR = 1.13; CI = 0.79–1.6; P = 0.504). Furthermore, no significant change in cardiovascular disease death risk was observed when comparing the lowest quartile of DKR with each subsequent quartile increase. In the Q4 group, the HRs of three COX models were as follows: model A (HR = 1.17; CI = 1.01–1.34; P = 0.033), model B (HR = 0.97; CI = 0.84–1.12; P = 0.706), and model C (HR = 0.95; CI = 0.83–1.10; P = 0.524).Similarly, in the adjusted C model that accounted for all covariates, our restricted cubic spline analysis revealed no discernible association between DKR and CVD mortality (refer to Fig. 3).

Fig. 3

Stratified analysis of the DKR and risk of all-cause mortality. DKR, dietary ketogenic ratio; BMI, Body Mass Index.

Full size image

Stratified and sensitivity analyses

In Model C, after adjusting for confounding factors, we conducted stratified analyses to determine the association between DKR and the risk of all-cause mortality as well as CVD mortality.The specific findings are presented in Table 3; Fig. 4. The results from the subgroup analyses were generally consistent with the overall outcomes, indicating that high DKR was linked to a reduced risk of all-cause mortality but not CVD mortality across different subgroups. In terms of subgroup analyses for all-cause mortality, no significant interactions were observed between DKR and male sex, age < 60 years, BMI < 24 kg/m2, smoking status, hypertension or diabetes. However, significant interactions were found among female participants, those aged ≥ 60 years old, individuals with BMI ≥ 24 kg/m2, non-smokers as well as non-hypertensive and non-diabetic patients. Notably, a more pronounced effect of DKR on the risk of all-cause mortality was noted within specific subgroups including women participants aged ≥ 60 years old with BMI ≥ 24 kg/m2 who were also non-smokers as well as non-hypertensive and non-diabetic patients. Regarding the association between DKR and CVD mortality, no significant cross-over effect was detected following corresponding subgroup analyses.

Table 3 Stratified analyses of the associations between DKR with all-cause and cardiovascular mortality.

Full size table

Fig. 4

Stratified analysis of the DKR and risk of cardiovascular mortality. DKR, dietary ketogenic ratio; BMI, Body Mass Index.

Full size image

Sensitivity analyses, excluding participants who died within 2 years after study entry or had missing information on covariates (refer to Supplementary Tables 1 and 2), as well as results that excluded patients with stroke or cancer (refer to Supplementary Tables 3 and 4), yielded consistent findings with the primary DKR analysis.

Discussion

• The KD has gained significant traction in recent years due to its potential health benefits, such as weight loss1 and improved metabolic health3. This study aims to investigate the impact of the KD on all-cause mortality and cardiovascular-related mortality by analyzing data from the NHANES spanning from 2001 to 2018. The findings demonstrate that the KD shows promise in reducing overall mortality risk without a concurrent increase in cardiovascular-related mortality, suggesting a potential protective effect against all-cause mortality. In this discussion, we will delve into the underlying mechanisms through which the KD may mitigate all-cause mortality while exploring reasons for its apparent lack of increased cardiovascular- related mortality risk.

• Our analysis of the NHANES dataset revealed a significant association between adherence to a KD and a reduction in overall mortality rates. This finding is consistent with previous research suggesting that following a KD may confer protective effects against various chronic diseases and conditions contributing to mortality.

• The KD exerts a multifaceted protective effect on all-cause mortality. Firstly, it has been demonstrated that the KD promotes metabolic health by facilitating weight loss15, attenuating inflammation16, and enhancing insulin sensitivity3. These factors play a pivotal role in reducing the risk of chronic conditions such as diabetes17, CVD18, and cancer19, which collectively contribute to overall mortality. Secondly, the KD has demonstrated neuroprotective effects, potentially contributing to a reduction in mortality rates. Research indicates that ketones, which are metabolic byproducts of fat breakdown in the KD, possess anti-inflammatory and antioxidant properties that can safeguard against neurodegenerative disorders20 and cognitive decline21-both of which are linked to an elevated risk of mortality. Furthermore, the KD has been demonstrated to modulate the gut microbiota, exerting a profound impact on overall health22. By fostering the proliferation of beneficial bacteria and mitigating harmful pathogens, the KD may contribute to the prevention of gastrointestinal diseases and enhancement of immune function, thereby diminishing mortality risk23. In addition, the KD has demonstrated efficacy in attenuating oxidative stress and enhancing mitochondrial function, both of which are pivotal determinants of aging and longevity24. By mitigating oxidative damage and facilitating efficient energy production, the KD holds promise for extending lifespan and reducing the susceptibility to age-related diseases. Finally, the KD has demonstrated its efficacy in exerting anti-inflammatory effects, which may also contribute to the reduction of all-cause mortality25. Chronic inflammation serves as a pivotal driver for numerous chronic diseases, and the anti-inflammatory properties associated with the KD have the potential to mitigate this risk and promote overall health and longevity.

• The impact of the KD on cardiovascular health has been a subject of debate due to its high-fat content. However, our analysis of the NHANES data suggests that despite its high fat intake, the KD does not increase mortality related to cardiovascular conditions. There are several mechanisms that may explain this phenomenon. Firstly, the KD has been demonstrated to enhance lipid profiles by elevating high-density lipoprotein (HDL) cholesterol and reducing triglyceride levels, both of which confer protection against CVD26. Despite its high saturated fat content, the diet primarily comprises unsaturated fats, which have been linked to a decreased risk of heart disease. Secondly, the KD has demonstrated efficacy in reducing inflammation, a pivotal factor in the pathogenesis of atherosclerosis and CVD27. Through its ability to attenuate inflammatory markers and cytokines within the body, the KD holds promise in impeding the progression of cardiac ailments and diminishing the risk of mortality associated with cardiovascular disorders. Furthermore, the KD has demonstrated efficacy in enhancing blood pressure regulation, which is a pivotal determinant of cardiovascular well-being6. By facilitating weight loss and mitigating insulin resistance, the KD may contribute to blood pressure reduction and diminish the likelihood of developing hypertension, a significant risk factor for CVD. Additionally, the KD has demonstrated efficacy in enhancing endothelial function, a pivotal factor in the pathogenesis of atherosclerosis and CVD. Through mitigation of oxidative stress and inflammation, the KD exhibits potential for safeguarding endothelial integrity and preserving vascular health, thereby mitigating the risk of cardiovascular-related mortality28. Lastly, the KD has the potential to enhance overall cardiac function and mitigate the risk of arrhythmias29 and heart failure30. Research indicates that ketones, which serve as the primary energy source in a KD, may offer superior efficiency and protection as an energy substrate for the heart31, resulting in improved cardiac performance and reduced incidence of cardiovascular events.

• In conclusion, our analysis of the NHANES data from 2001 to 2018 indicates that the KD holds potential in reducing all-cause mortality while not increasing cardiovascular-related mortality. The observed mechanisms underly- ing these effects encompass enhancements in metabolic health3, neuroprotection20, modulation of gut microbiota22, antioxidant and anti- inflammatory properties24, as well as overall prevention of age-related diseases. Further research is warranted to elucidate the specific pathways through which the KD exerts these effects and optimize its implementation for long-term health and longevity.

• Therefore, the ketogenic diet, as a specific dietary pattern, holds potential benefits from a public health perspective by offering innovative therapeutic approaches for patients with obesity, metabolic syndrome, and certain refractory diseases. By implementing scientifically and logically tailored dietary adjustments, the ketogenic diet can contribute to improving the health status of these patients, mitigating the societal medical burden, and enhancing overall well-being. However, it is important to acknowledge that the suitability of the ketogenic diet may vary among individuals. Its stringent restrictions and high fat intake could potentially exert adverse effects on specific populations such as imposing additional strain on liver function and disrupting nutrient balance. Therefore, personalized guidance and vigilant monitoring should be emphasized during the promotion and application of KD to ensure its positive impact on public health.

Limitations

• To ensure a comprehensive understanding of the findings, it is imperative to address the limitations of this study. Firstly, although rigorous data handling and statistical analysis indicate a potential trend towards reduced all-cause mortality risk without an increased risk of death from cardiovascular causes, the absence of direct measurement of ketosis levels poses a significant constraint in examining the relationship between ketosis and mortality risk. This hypothetical inference may not accurately reflect true ketosis status and could have influenced our study results. Therefore, future studies will employ more precise methods for directly measuring ketosis levels to comprehensively assess its potential association with all-cause mortality.

• Furthermore, the assessment of dietary habits in this study was solely reliant on self-administered questionnaires without repeated measurements, which may introduce temporal instability when estimating dietary patterns. Although the dietary data in the NHANES database are derived from cross-sectional sampling with appropriate research design, data selection, and statistical analysis methods to provide valuable insights into associations between disease or health conditions and exposure factors, they cannot establish direct causal relationships.To address this limitation, future studies will explicitly discuss employing more rigorous methods for measuring dietary habits such as utilizing multiple repeated questionnaires or other objective dietary assessment tools to ensure precise and consistent eval‎uation of dietary patterns. In the future, through further research and technological advancements, we aim to acquire a more comprehensive understanding of the benefits and risks associated with ketogenic diets while making significant contributions to public health and well-being.

Conclusions

Our retrospective study suggests that the ketogenic diet may potentially reduce all-cause mortality without a concurrent increase in cardiovascular-related mortality. This finding underscores the significance of further research and exploration into the potential advantages of the ketogenic diet in promoting overall health and longevity. It is imperative for healthcare providers and policymakers to consider the potential impact of dietary interventions, such as the ketogenic diet, on reducing mortality rates and improving public health outcomes. Additional investigations are warranted to comprehensively comprehend the mechanisms underlying these observed associations and ascertain the feasibility and long-term sustainability of implementing a ketogenic diet for population-wide health benefits.

결론
우리의 회고적 연구 결과, 

케토제닉 식단이 심혈관 관련 사망률의 동시 증가 없이 

전체 사망률을 감소시킬 수 있다는 가능성이 제시되었습니다. 

이 결과는 케토제닉 식단이 

전반적인 건강과 수명 연장 촉진에 대한 잠재적 이점을 탐구하는 

추가 연구의 중요성을 강조합니다.

 의료진과 정책 입안자들은 케토제닉 식단과 같은 식이 개입이 사망률 감소와 공중 보건 결과 개선에 미치는 잠재적 영향을 고려해야 합니다. 추가 연구가 필요하며, 관찰된 연관성의 기전을 포괄적으로 이해하고 인구 전체의 건강 혜택을 위해 케토제닉 식단을 도입하는 것의 실현 가능성과 장기적 지속 가능성을 확인해야 합니다.

Data availability

The present study utilized publicly available datasets, which can be accessed at the National Center for Health Statistics (NHANES) website: https://wwwn.cdc.gov/nchs/nhanes.

References

1. Di Rosa, C. et al. Mediterranean Diet versus very low-calorie ketogenic diet: Effects of reaching 5% body weight loss on body composition in subjects with overweight and with Obesity-A cohort study. Int. J. Environ. Res. Public. Health. 19(20). https://doi.org/10.3390/ijerph192013040 (2022).

2. Pizzo, F. et al. Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis. Expert Rev. Neurother.22(2), 169–177. https://doi.org/10.1080/14737175.2022.2030220 (2022).

   Article CAS PubMed Google Scholar 

3. Aronica, L. et al. Weight, insulin resistance, blood lipids, and diet quality changes associated with ketogenic and ultra low-fat dietary patterns: A secondary analysis of the DIETFITS randomized clinical trial. Front. Nutr.10, 1220020. https://doi.org/10.3389/fnut.2023.1220020 (2023).

   Article CAS PubMed PubMed Central Google Scholar 

4. Chinna-Meyyappan, A. et al. Effects of the ketogenic diet on cognition: A systematic review. Nutr. Neurosci.26(12), 1258–1278. https://doi.org/10.1080/1028415X.2022.2143609 (2023).

   Article PubMed Google Scholar 

5. Xu, X. et al. Ketogenic diet inhibits neointimal hyperplasia by suppressing oxidative stress and inflammation. Clin. Exp. Hypertens.45(1), 2229538. https://doi.org/10.1080/10641963.2023.2229538 (2023).